ImuVert therapy in the treatment of recurrent malignant astrocytomas: nursing implications.

@article{Cress1991ImuVertTI,
  title={ImuVert therapy in the treatment of recurrent malignant astrocytomas: nursing implications.},
  author={N B Cress and Barry M Owens and Frank G. H. Hill},
  journal={The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses},
  year={1991},
  volume={23 1},
  pages={29-33}
}
Malignant astrocytoma is a fatal, primary brain tumor affecting adults in the prime of life. Even with optimal treatment, median life expectancy from time of diagnosis is 51 weeks. Standard therapy consists of surgical debulking, radiation therapy and chemotherapy. Immunotherapy, utilizing biologic response modifiers (BRMs), affords one of the more… CONTINUE READING